BAX and hypopharyngeal carcinoma: An increasing body of evidence suggests that in hypopharyngeal carcinoma, chemotherapeutic agents such as cisplatin activate p53 by inducing DNA damage, thereby upregulating Bax and promoting apoptosis [12,13,14,15,16,17,18,22,23].